Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Congenital Anomalies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT06219902
What this trial is testing

Learn if Elinzanetant Affects the Ability to Drive and Brain Function in Healthy Women

Who this might be right for
Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and MenHot Flashes
Bayer 64
Large-scale testing (Phase 3)Study completedNCT00790400
What this trial is testing

Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)

Who this might be right for
Tuberous Sclerosis Complex (TSC)Lymphangioleiomyomatosis (LAM)
Novartis Pharmaceuticals 118
Not applicableStudy completedNCT03889392
What this trial is testing

Evaluation of Nephrectomy Specimen for Intracranial Aneurysm Development in ADPKD

Who this might be right for
Kidney Transplant; ComplicationsAneurysm, BrainPolycystic Kidney Diseases
Asan Medical Center 154
Early research (Phase 1)UnknownNCT05969977
What this trial is testing

A First-in-Human Phase 1 Study of Plasmalogen Precursor PPI-1011 in Healthy Adult Volunteers to Assess Safety, Tolerability, and Pharmacokinetics

Who this might be right for
Rhizomelic Chondrodysplasia Punctata
MED-LIFE DISCOVERIES LP 56
Not applicableStudy completedNCT00786019
What this trial is testing

Influence of Endothelial Function on Central and Peripheral Causes Of Exercise Impairment in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
University of Colorado, Denver 47
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06487000
What this trial is testing

Determine the Dose-dependent Efficacy and Safety of EC-18 in Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Enzychem Lifesciences Corporation 150
Not applicableStudy completedNCT04804397
What this trial is testing

Effects of Sucrose Added Blind to the Diet Over Eight Weeks on Body Mass and Weight in Men

Who this might be right for
Overweight
University of Hull 80
Large-scale testing (Phase 3)Study completedNCT02119013
What this trial is testing

Effects of Somatostatin on ADPKD Heart

Who this might be right for
Autosomal Dominant Polycystic Kidney DiseaseGlomerular Filtration Rate > 40 ml/Min
Federico II University 35
Early research (Phase 1)Study completedNCT01590446
What this trial is testing

Evaluate Safety and Tolerability of BMN 111 Administered to Healthy Adult Volunteers

Who this might be right for
Achondroplasia
BioMarin Pharmaceutical 74
Not applicableStudy completedNCT00296023
What this trial is testing

Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
University of California, San Francisco 25
Testing effectiveness (Phase 2)Study completedNCT04300790
What this trial is testing

Study to Evaluate the Effect of Metformin in the Prevention of HG in HR[+]/HER2[-] PIK3CA-mut Advanced BC Patients

Who this might be right for
Breast Cancer
MedSIR 69
Large-scale testing (Phase 3)Not Yet RecruitingNCT07782827
What this trial is testing

CHAMPION: A Study to Evaluate the Efficacy and Safety of Obudanersen (ION582) in Children and Adults With Angelman Syndrome (AS)

Who this might be right for
Angelman Syndrome
Ionis Pharmaceuticals, Inc. 30
Testing effectiveness (Phase 2)UnknownNCT04413942
What this trial is testing

Evaluate Efficacy, PK, and Safety of FB825 in Adults With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Oneness Biotech Co., Ltd. 99
Not applicableStudy completedNCT00450918
What this trial is testing

Evaluating Progression of and Diagnostic Tools for Primary Ciliary Dyskinesia in Children and Adolescents

Who this might be right for
Primary Ciliary Dyskinesia
University of North Carolina, Chapel Hill 150
Large-scale testing (Phase 3)Study completedNCT00638703
What this trial is testing

Study to Evaluate the Efficacy and Safety of OxabactTM on Reduction of Urinary Oxalate in Primary Hyperoxaluria Patients

Who this might be right for
Primary Hyperoxaluria
OxThera 43
Not applicableStudy completedNCT04735874
What this trial is testing

Vascular Health and Risk Factors in Children With Down Syndrome

Who this might be right for
Down SyndromeCardiovascular Risk FactorAtherosclerosis
University of Utah 55
Early research (Phase 1)Study completedNCT01205724
What this trial is testing

Safety and Pharmacokinetics of NNC 0129-0000-1003 in Subjects With Haemophilia A

Who this might be right for
Congenital Bleeding DisorderHaemophilia A
Novo Nordisk A/S 27
Not applicableUnknownNCT04037579
What this trial is testing

Protocol for a Non-randomized Survey in Down Syndrome People Who Practice Sports. Self and Observers´ Perception.

Who this might be right for
Down SyndromeSocial SkillsPhysical Activity
Universidad de Córdoba 300
Not applicableUnknownNCT02163603
What this trial is testing

A Trial on the Opportunity and Treatment of Residual Deformity After Reduction in Developmental Dislocation of the Hip

Who this might be right for
Developmental Dislocation of the HipCongenital Dislocation of HipResidual Deformity+1 more
Hongwen Xu 2
Testing effectiveness (Phase 2)Study completedNCT02706886
What this trial is testing

Study of Lumasiran in Healthy Adults and Patients With Primary Hyperoxaluria Type 1

Who this might be right for
Primary Hyperoxaluria Type 1 (PH1)
Alnylam Pharmaceuticals 52
Next Page